Members of the biotech industry have voiced concerns about the impact of the BIOSECURE Act, after the bill passed through the ...

Kisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData ...

A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK 's new drug application (NDA) for Blenrep ...

Ossium Health’s PRESERVE I trial is evaluating the safety and effectiveness of its deep-frozen bone marrow from deceased ...

Nura Bio has secured additional $68m in a Series A financing round to advance the development of its neuroprotective ...

The Israeli Ministry of Health granted approval for BeiGene’s TEVIMBRA for unresectable or metastatic oesophageal squamous ...

Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.

The partnership will see AI-enabled screening used to address bioavailability issues with Equillium’s cytokine-targeting ...

The company claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

The clinical hold was placed on three studies investigating azenosertib in June after two patients died due to presumed ...